5Caponigro F.Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. Anti Cancer Drugs . 2004 被引量：1
6Soulieres D,SenzerNN,Vokes EE,et al.Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patientswith recurrent ormetastatic squamous cell cancer of the head and neck. Journal of Clinical Oncology . 2004 被引量：1
二级参考文献30
1Benninger MS.Microdissection or microspot CO2laser for limited vocal fold benign lesions: a prospective randomized trial.Laryngoscope.2000; 110( Suppl): 1-17. 被引量：1
2Peretti G, Piazza C, Balzanelli C,et al.Vocal outcome after endo scopic cordectomies for Tis and T1 glottic carcinomas.Ann Otol Rhinol Laryngol.2003;112: 174-179. 被引量：1
3Vikram B, Strong EW, Shah JP, et al.Failure at the primary site following multimodality treatment in advanced head and neck cancer.Head Neck Surg.1984; 6: 720-723. 被引量：1
4Looser KG, Shah IP, Strong EW.The significance of "positive" margins in surgically resected epidermoid carcinoma.Head Neck Surg.1978; 1: 107-111. 被引量：1
5Remacle M, Lawson G.Transoral laser microsurgery is the recommended treatment for early glottic cancers.Acta Otorhinolaryngol Belg.1999; 53: 175-178. 被引量：1
6Byers RM, Wolf PF, Ballantyne AJ.Rationale for elective modified neck dissection.Head Neck Surg.1988; 10: 160-167. 被引量：1
7Hirayama M, Takahashi H, Yao K, et al.Clinical study of T1a glottic-type cancer.Acta Otolaryngol.2002;(Suppl 547):67-71. 被引量：1
8Shvero J, Koren R, Zohar L, et al.Laser surgery for the treatment of glottic carcinomas.Am J Otolaryngol.2003;24: 28-33. 被引量：1
9Yumi Knegae, Miho Makimura and Izumu Satio. A simple and efficient method for purifica-tion of infections recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166. 被引量：1
10Brand K, Klocke R, Pobetaling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063. 被引量：1
4Wang X M, Wang X F, Li J, et al. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines [ J ]. Ann Surg, 1998, 227(6) : 922 -931. 被引量：1
5Kim D H, Kim M, Kwon H J. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents [ J]. J Biochem Mol Biol, 2003, 36(1): 110-119. 被引量：1
6Takai N, Desmond J C, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells[ J]. Clin Cancer Res, 2004, 10(3) : 1141 -1149. 被引量：1
7Wong S C, Chan J K, Lee K C, et al. Differential expression of p16/ p21/p27 and cyclin D1/D3 and their relationships to cell proliferation, apoptosis and tumour progression in invasive ductal carcinoma of the breast[J]. J Pathol, 2001, 194(1) : 35 -42. 被引量：1
8Shin S, Sung B J, Cho Y S, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 [ J ]. Biochemistry, 2001, 40(4): 1117-1123. 被引量：1
